arrow
A

Ankur Jindal

institute of liver and biliary sciences
H指数:32
被引数:4,982

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Addition of midodrine to albumin reduces the incidence of complications of large-volume paracentesis: an RCT comparing midodrine, terlipressin, and albumin

加用米多君联合白蛋白可降低大量腹腔穿刺术并发症的发生率:一项比较米多君、特利加压素和白蛋白的随机对照试验

2025-07-040
PRE
Comparison of relaxed verses standard cut-offs of rotational thromboelastometry for guiding blood product use before invasive procedures in advanced cirrhosis: a randomized controlled trial

比较放松与标准切点值的旋转血栓弹力图对指导晚期肝硬化患者行侵入性操作前血液制品使用的疗效:一项随机对照试验

2025-05-210
PRE
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia

急慢性肝衰竭(ACLF):来自亚洲的“京都共识”进展

2025-02-170
OAAI
A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study (VOL 119, 1706, 2024)
2024-03-040
PRE
Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy

长期HBsAg反应聚乙二醇干扰素Alpha-2b在HBeAg阴性慢性乙型肝炎患者停止长期核苷 (酸) 类似物治疗后发展为临床复发

2024-01-013
PRE
Development and validation of a machine learning-based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter study

代偿性肝硬化静脉曲张筛查基于机器学习的模型的开发和验证 (CHESS2001): 一项国际多中心研究

2023-03-014
PRE